Patents by Inventor David S. Soriano

David S. Soriano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4705896
    Abstract: Novel ortho alkoxy substituted phenyl oxime compounds which are useful for selectively separating and recovering palladium from aqueous compositions and mixtures containing palladium and other metals.
    Type: Grant
    Filed: June 25, 1984
    Date of Patent: November 10, 1987
    Assignee: Allied Corporation
    Inventors: Michael Van Der Puy, David S. Soriano, Jeffrey H. Dimmit
  • Patent number: 4633005
    Abstract: Allylphosphonate diesters are prepared by reacting an appropriate allyl halide or alcohol with an appropriate phosphite compound in the presence of a catalytically effective amount of a phosphinated d.sup.8 transition metal catalyst.
    Type: Grant
    Filed: July 2, 1984
    Date of Patent: December 30, 1986
    Assignee: Allied Corporation
    Inventors: David Nalewajek, David S. Soriano
  • Patent number: 4582652
    Abstract: Allyl phosphonate diesters are converted to vinyl phosphonate diesters by isomerization with a catalytically effective amount of one or more metal hydroxide catalysts.
    Type: Grant
    Filed: July 2, 1984
    Date of Patent: April 15, 1986
    Assignee: Allied Corporation
    Inventors: David Nalewajek, David S. Soriano
  • Patent number: 4578250
    Abstract: The present invention is directed to a method of separating and purifying palladium which is present in a solution with at least one other platinum group metal by adjusting the pH of the solution to from about 0 to 5, contacting the acidified solution with an ortho alkoxy substituted phenyl oxime of the formula: ##STR1## or a composition comprising of one or more of said compounds dissolved in an organic solvent, wherein:n is an integer of from 1 to 4;R.sub.1 is alkyl, cycloalkyl, or aralkyl; andR.sub.2 is nitro, halogen, hydrogen or substituted ro unsubstituted alkyl, alkoxy, aryloxy, cycloalkyl, aryl, aralkyl or alkaryl, wherein permissible substituents are those which are inert to process conditions; andR.sub.
    Type: Grant
    Filed: July 2, 1984
    Date of Patent: March 25, 1986
    Assignee: Allied Corporation
    Inventors: Jeffrey H. Dimmit, Michael Van Der Puy, David S. Soriano
  • Patent number: 4548763
    Abstract: Allylphosphonate diesters are converted to vinyl phosphonate diesters by isomerization with a catalytic amount of a ruthenium catalyst. Vinyl phosphonate derivatives are produced directly from an organo pentavalent phosphorus compound. In a particular reaction conversion of allylic phosphonate diesters to vinylic phosphonate diesters is accomplished by the transition metal mediated isomerization of the alkylphosphonate derivatives with tetrakis(triphenylphosphine)dihydrido ruthenium(II).
    Type: Grant
    Filed: December 5, 1983
    Date of Patent: October 22, 1985
    Assignee: Allied Corporation
    Inventors: David Nalewajek, David S. Soriano, Ralph J. Borowski
  • Patent number: 4507251
    Abstract: Novel .beta.-oximinoalkylphosphonic acid ester derivatives of general formula B are prepared from the corresponding .alpha.-halo oxime A: ##STR1## wherein R.sup.1 is a substituent selected from the group consisting of H and C.sub.1 -C.sub.20 alkyl, cycloalkyl and aryl substituents;R.sup.2 is a substituent selected from the group consisting of H and C.sub.1 to C.sub.20 linear alkyl and aryl substituents;R.sup.3 is a substituent selected from the group consisting of H and C.sub.1 to C.sub.20 alkyl, cycloalkyl, 1-alkoxy alkyl, aryl, acyl, N-substituted carbamoyl, N,N-disubstituted carbamoyl and nitrogen- , oxygen- , sulfur- , and phosphorus-containing heterocyclic substituents;R.sup.4 is an alkyl substituent of C.sub.1 to C.sub.20 aryl; andX is a substituent selected from the group consisting of Cl, Br, I.In a specific reaction, the .alpha.-halo oxime derivative is dissolved in an excess of trialkyl phosphite, greater than 3 molar equivalents is preferred. The preference for the .alpha.
    Type: Grant
    Filed: July 26, 1982
    Date of Patent: March 26, 1985
    Assignee: Allied Corporation
    Inventors: David S. Soriano, Timothy R. Demmin, Martin A. Robinson